These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27475749)

  • 41. Correlation between anti-Ro/La titers and clinical findings of patients with systemic lupus erythematosus.
    Chien JW; Lin CY; Yang LY
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 May; 64(5):283-91. PubMed ID: 11499338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nasal carriers are more likely to acquire exogenous Staphylococcus aureus strains than non-carriers.
    Ghasemzadeh-Moghaddam H; Neela V; van Wamel W; Hamat RA; Shamsudin MN; Hussin NS; Aziz MN; Haspani MS; Johar A; Thevarajah S; Vos M; van Belkum A
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e1-7. PubMed ID: 26183299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
    Ippolito A; Wallace DJ; Gladman D; Fortin PR; Urowitz M; Werth V; Costner M; Gordon C; Alarcón GS; Ramsey-Goldman R; Maddison P; Clarke A; Bernatsky S; Manzi S; Bae SC; Merrill JT; Ginzler E; Hanly JG; Nived O; Sturfelt G; Sanchez-Guerrero J; Bruce I; Aranow C; Isenberg D; Zoma A; Magder LS; Buyon J; Kalunian K; Dooley MA; Steinsson K; van Vollenhoven RF; Stoll T; Weisman M; Petri M
    Lupus; 2011 Mar; 20(3):250-5. PubMed ID: 21362750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and serological correlates of anti-Sm autoantibodies in Chinese patients with systemic lupus erythematosus: 1,584 cases.
    Ni JD; Yao X; Pan HF; Li XP; Xu JH; Ye DQ
    Rheumatol Int; 2009 Sep; 29(11):1323-6. PubMed ID: 19194707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations.
    Borba EF; Araujo DB; Bonfá E; Shinjo SK
    Lupus; 2013 Jun; 22(7):744-9. PubMed ID: 23687065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.
    Rai R; Chauhan SK; Singh VV; Rai M; Rai G
    PLoS One; 2016; 11(11):e0166312. PubMed ID: 27835693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.
    Pruzanski W; Goulding NJ; Flower RJ; Gladman DD; Urowitz MB; Goodman PJ; Scott KF; Vadas P
    J Rheumatol; 1994 Feb; 21(2):252-7. PubMed ID: 8182633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.
    Flechsig A; Rose T; Barkhudarova F; Strauss R; Klotsche J; Dähnrich C; Schlumberger W; Enghard P; Burmester GR; Hiepe F; Biesen R
    Clin Exp Rheumatol; 2017; 35(4):598-606. PubMed ID: 28281463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    To CH; Petri M
    Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients.
    Choi JH; Park DJ; Kang JH; Yim YR; Lee KE; Lee JW; Wen L; Kim TJ; Park YW; Lee JK; Lee SS
    Lupus; 2015 Oct; 24(12):1342-9. PubMed ID: 26085595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
    Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
    Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
    Urowitz MB; Anton A; Ibanez D; Gladman DD
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE.
    Galeazzi M; Morozzi G; Sebastiani GD; Bellisai F; Marcolongo R; Cervera R; De Ramòn Garrido E; Fernandez-Nebro A; Houssiau F; Jedryka-Goral A; Mathieu A; Papasteriades C; Piette JC; Scorza R; Smolen J
    Clin Exp Rheumatol; 1998; 16(5):541-6. PubMed ID: 9779300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.
    Tozkir H; Pamuk ON; Duymaz J; Gurkan H; Yazar M; Sari G; Tanrikulu H; Pamuk GE
    Int J Rheum Dis; 2016 Dec; 19(12):1304-1309. PubMed ID: 25292400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus.
    Vordenbäumen S; Böhmer P; Brinks R; Fischer-Betz R; Richter J; Bleck E; Rengers P; Göhler H; Zucht HD; Budde P; Schulz-Knappe P; Schneider M
    Rheumatology (Oxford); 2018 Mar; 57(3):533-537. PubMed ID: 29267954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.